Aravive Inc (ARAV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARAV | ZVSA | VRPX | ||
| Company | Aravive Inc | Zyversa Therapeutics Inc | Virpax Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.0435 | 3.75 | 1.5500 | ||
| High | 0.0460 | 3.90 | 1.5500 | ||
| Low | 0.0401 | 3.71 | 1.3500 | ||
| Last | 0.0401 | 3.85 | 1.3800 | ||
| Change | -0.0062 | unch | -0.1300 | ||
| % Change | -13.39% | unch | -8.61% | ||
| Volume | 4,040,000 | 30,700 | 590,800 | ||
| 20-Day Average Volume | 3,905,935 | 281,540 | 18,287,219 | ||
| Previous Close | 0.0463 | 3.85 | 1.5100 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.0945 | 4.14 | 1.2249 | ||
| 20-Day Raw Stochastic | 0.11% | 12.66% | 30.84% | ||
| 20-Day Relative Strength | 26.22% | 44.58% | 52.05% | ||
| Weighted Alpha | -75.45 | -88.18 | -76.60 | ||
| Today's Opinion | 100% Sell | 96% Sell | 40% Sell | ||
| Previous Opinion | 100% Sell | 96% Sell | 40% Sell | ||
| Last Month's Opinion | 100% Sell | 100% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -23.18% since 01/19/24 | -1.53% since 07/19/24 | -18.82% since 07/19/24 | ||
| Low | 0.0400 on 01/23/24 | 3.60 on 07/25/24 | 1.3500 on 07/26/24 | ||
| High | 0.0530 on 01/22/24 | 4.20 on 07/25/24 | 1.8900 on 07/24/24 | ||
| 1-Month | |||||
| %Chg | -68.75% since 12/26/23 | +2.94% since 06/26/24 | +177.28% since 06/26/24 | ||
| Low | 0.0400 on 01/23/24 | 3.49 on 07/01/24 | 0.4835 on 07/01/24 | ||
| High | 0.1292 on 01/02/24 | 6.30 on 07/10/24 | 3.3900 on 07/10/24 | ||
| 3-Month | |||||
| %Chg | -70.73% since 10/26/23 | -22.85% since 04/26/24 | -55.48% since 04/26/24 | ||
| Low | 0.0400 on 01/23/24 | 3.41 on 06/26/24 | 0.4603 on 06/21/24 | ||
| High | 0.1820 on 11/30/23 | 6.70 on 04/29/24 | 3.3900 on 07/10/24 | ||
| 6-Month | |||||
| %Chg | -97.18% since 07/26/23 | -41.73% since 01/26/24 | -55.50% since 01/26/24 | ||
| Low | 0.0400 on 01/23/24 | 3.41 on 06/26/24 | 0.4603 on 06/21/24 | ||
| High | 1.5050 on 07/31/23 | 25.00 on 02/26/24 | 5.4800 on 03/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,950 | 3,214 | 2,909 | ||
| Shares Outstanding, K | 73,563 | 835 | 2,108 | ||
| Annual Sales | 9,140,000 | 0 | 0 | ||
| Annual Net Income | -76,320,000 | -98,300,000 | -15,190,000 | ||
| Last Quarter Sales | 2,760,000 | 0 | 0 | ||
| Last Quarter Net Income | 21,230,000 | -2,830,000 | -3,220,000 | ||
| 60-Month Beta | 2.19 | 0.66 | 1.16 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.10 on 11/09/23 | -4.53 on 05/15/24 | -2.75 on 05/13/24 | ||
| Latest Earnings Date | 08/19/24 | 08/19/24 | 08/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||